Safety and efficacy of nivolumab applied at different dosage in the patients with relapsing Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation

Autor:	L Alyanskiy Alexander, V Lepik Kirill, N Bondarenko Sergey, S Moiseev Ivan, B Mikhailova Natalya, V Kondakova Elena, V Kozlov Andrey, O Popova Marina, S Borzenkova Evgeniya, I Darskaya Elena, G Gevorgyan Asmik, A Tsvetkova Luibov, V Afanasyev Boris
Rok vydání:	2018
Předmět:	Oncology Transplantation medicine.medical_specialty business.industry medicine.medical_treatment Allo hsct Hematopoietic stem cell transplantation Hodgkin's lymphoma medicine.disease Internal medicine medicine Molecular Medicine Hodgkin lymphoma Nivolumab business
Zdroj:	Cellular Therapy and Transplantation. 7:28-35
ISSN:	1866-8836
DOI:	10.18620/ctt-1866-8836-2018-7-2-28-35
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d04167896982e0d1525c71f29e684379 https://doi.org/10.18620/ctt-1866-8836-2018-7-2-28-35 Zobrazit plný text záznamu